Abstract
The purpose of this investigation was to assess the clinical characteristics, therapeutic aspects, and outcome of arthritis related to invasive meningococcal disease (IMD). All episodes of bacterial meningitis and IMD are recorded systematically. We selected all episodes of IMD, with or without meningitis, that presented arthritis. From 1977 to 2010, 522 episodes of IMD were treated. Thirty-nine of these (7.5 %, 26 women, mean age 33 years) presented arthritis. Of these 39, 37 (95 %) presented skin lesions and 31 (79 %) had meningitis. Twenty (51 %) had positive blood cultures and six (15 %) had shock. No differences were found in skin lesions, shock, or bacteremia compared to cases without arthritis. In contrast to other septic forms, arthritis related to IMD was cured with short antibiotic therapy and without surgical drainage. There was no mortality. All patients recovered and none presented joint sequelae; however, 13 adult patients (33 %) required long-term treatment with steroids due to persistent symptoms. Arthritis related to IMD most frequently affects the knees and ankles, and may be a cause of fever relapse. Short antibiotic therapy is enough in all cases and surgical drainage is not needed. In some adult patients, especially those over 50 years of age, evolution is torpid and steroid therapy may be required in order to achieve recovery.
Similar content being viewed by others
References
Fronz E (1897) Ueber eiterige Gelenksentzündungen im Verlaufe der Meningitis cerebrospinalis epidemica. Wien Klin Wochenschr 10:351–353
Gwyn NB (1899) A case of general infection by the Diplococcus intracellularis of Weichselbaum. Bull Johns Hopkins Hosp 10:112–113
Osler W (1898) The arthritis of cerebro-spinal fever. Boston Med Surg J 139:641–643
Still GF (1898) The bacteriology of the simple posterior basic meningitis of infants. J Pathol Bacteriol 5:147–159
Schaad UB (1980) Arthritis in disease due to Neisseria meningitidis. Rev Infect Dis 2:880–888
Goedvolk CA, von Rosenstiel IA, Bos AP (2003) Immune complex associated complications in the subacute phase of meningococcal disease: incidence and literature review. Arch Dis Child 88:927–930
Kidd BL, Hart HH, Grigor RR (1985) Clinical features of meningococcal arthritis: a report of four cases. Ann Rheum Dis 44:790–792
Janda WM, Gaydos CA (2007) Neisseria. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. American Society for Microbiology, Washington DC, pp 601–620
Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100-S20. ISBN 1-56238-588-7. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087–1898 USA
Viladrich PF, Pallarés R, Ariza J, Rufí G, Gudiol F (1986) Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 146:2380–2382
Dillon M, Nourse C, Dowling F, Deasy P, Butler K (1997) Primary meningococcal arthritis. Pediatr Infect Dis J 16:331–332
Weisfelt M, van de Beek D, Spanjaard L, de Gans J (2006) Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis 6:64
Germino KW, Street MH, Caudill KA, Barenkamp SJ (2009) An unusual cause of acute polyarticular arthritis. Clin Pediatr (Phila) 48:220–223
Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM (2003) The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis 37:1639–1642
Sud R, Bhatnagar MK, Sud A, Tiwari A (2009) Incidence and outcome of arthritis in meningococcal disease. J Indian Med Assoc 107:156, 158–159
Brouwer MC, Heckenberg SGB, Van der Ende A, Van de Beek (2011) No harm of adjunctive dexamethasone in meningococcal meningitis. In: Proceedings of the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, 17–20 September 2011. Abstract L1-1920
Keeling PWN, Aston NO, Croft DN (1980) Steroid-responsive vasculitis and arthritis in meningococcal septicaemia. Postgrad Med J 56:800–801
Dass R, Barman H, Duwarah SG, Deka NM, Jain P, Choudhury V (2010) Immune complex reaction after successful treatment of meningococcal disease: an excellent response to IVIG. Rheumatol Int. Epub ahead of print. doi:10.1007/s00296-010-1555-6
Chin KR, Miller BS, Koris MJ (2002) Serous flexor tenosynovitis as an associated finding in meningococcal septic polyarthritis. Am J Orthop (Belle Mead NJ) 31:88–89
Pollet SM, Leek JC (1987) Tenosynovitis in meningococcemia. Arthritis Rheum 30:232–233
Rosen MS, Myers AR, Dickey B (1985) Meningococcemia presenting as septic arthritis, pericarditis, and tenosynovitis. Arthritis Rheum 28:576–578
Fayé A, Mariani-Kurkdjian P, Taha M-K, Angoulvant F, Antonios M, Aubertin G, Soussan V, Bingen E, Bourrillon A (2004) Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis 38:1635–1637
Bhavnagri S, Steele N, Massasso D, Benn R, Youssef P, Bleasel J (2008) Meningococcal-associated arthritis: infection versus immune-mediated. Intern Med J 38:71–73
García-De la Torre I (2003) Advances in the management of septic arthritis. Rheum Dis Clin North Am 29:61–75
Acknowledgments
C. Cabellos, J. Ariza, and P.F. Viladrich are members of the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008/0022). None of the authors has received any financial support for this work and none declares any conflict of interest or commercial relationship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cabellos, C., Nolla, J.M., Verdaguer, R. et al. Arthritis related to systemic meningococcal disease: 34 years’ experience. Eur J Clin Microbiol Infect Dis 31, 2661–2666 (2012). https://doi.org/10.1007/s10096-012-1610-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1610-1